Not applicableNot Yet RecruitingNCT06432855What this trial is testingGenetic Determinants of the Antiviral Immune Response in Oceanian PopulationsWho this might be right forVirus Institut Pasteur 220
Not applicableStudy completedNCT02948933What this trial is testingCohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue VaccineWho this might be right forDengue FeverDengue Hemorrhagic Fever Sanofi Pasteur, a Sanofi Company 30,000
Not applicableActive Not RecruitingNCT05138055What this trial is testingThe NOrwegian Tick-borne Encephalitis StudyWho this might be right forTick-Borne Encephalitis, European Sykehuset Telemark 153
Large-scale testing (Phase 3)Study completedNCT00605085What this trial is testingSafety and Tolerability of the Japanese Encephalitis Vaccine IC51Who this might be right forJapanese Encephalitis Valneva Austria GmbH 2,675
Not applicableStudy completedNCT04697147What this trial is testingZika and Neurodevelopment Among Infants in GrenadaWho this might be right forZika Virus InfectionNeurocognitive DeficitDevelopment, Child+1 more Windward Islands Research and Education Foundation 148
Large-scale testing (Phase 3)Study completedNCT05349617What this trial is testingSafety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 YearsWho this might be right forChikungunya Virus Bavarian Nordic 413
Early research (Phase 1)Study completedNCT00322946What this trial is testingSafety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-4995) in Healthy AdultsWho this might be right forDengue National Institute of Allergy and Infectious Diseases (NIAID) 84
Large-scale testing (Phase 3)Study completedNCT00595465What this trial is testingComparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51Who this might be right forJapanese Encephalitis Valneva Austria GmbH 389
Early research (Phase 1)Study completedNCT00118924What this trial is testingSafety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy AdultsWho this might be right forTick-Borne Encephalitis National Institute of Allergy and Infectious Diseases (NIAID) 28
Early research (Phase 1)Study completedNCT04722627What this trial is testingStudy of AT-752 in Healthy SubjectsWho this might be right forDengue Atea Pharmaceuticals, Inc. 65
Not applicableNot Yet RecruitingNCT07002021What this trial is testingEffectiveness Evaluation of the "Mosquito-Free Campus" Initiative on Dengue Fever Prevention and Control: A Cluster Randomized Controlled TrialWho this might be right forDengueInfection Prevention Sun Yat-sen University 3,940
Not applicableStudy completedNCT03158233What this trial is testingZika Case Definition and Surveillance StudyWho this might be right forZika Virus Disease Sanofi Pasteur, a Sanofi Company 2,400
Not applicableNot Yet RecruitingNCT06674837What this trial is testingDiagnostics and Surveillance of Acute Meningo-encephalitis Among Children in Cambodia With a Focus on Japanese Encephalitis VirusWho this might be right forJapanese Encephalitis ANRS, Emerging Infectious Diseases 4,000
Early research (Phase 1)Study completedNCT01502358What this trial is testingEvaluation of the Safety and the Ability of a DNA Vaccine to Protect Against Dengue DiseaseWho this might be right forDengue DiseaseDengue Fever U.S. Army Medical Research and Development Command 40
Not applicableStudy completedNCT02831699What this trial is testingThe Evaluation of Potential Zika, Chikungunya, and Dengue Infections in MexicoWho this might be right forZika Virus Disease (Disorder)DengueChikungunya Mexican Emerging Infectious Diseases Clinical Research Network 600
Not applicableWithdrawnNCT03229421What this trial is testingDermatologic Manifestations of Zika VirusWho this might be right forZika Virus Symptoms and the Associated Exanthema Northwestern University
Not applicableStudy completedNCT01983553What this trial is testingLong-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy StudyWho this might be right forDengueDengue FeverDengue Hemorrhagic Fever Sanofi Pasteur, a Sanofi Company 3,203
Post-approval studies (Phase 4)Study completedNCT00311441What this trial is testingStudy of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy ChildrenWho this might be right forEncephalitis, Tick-Borne Novartis 300
Post-approval studies (Phase 4)Study completedNCT01815073What this trial is testingImmunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE VaccineWho this might be right forJapanese EncephalitisChickenpox Changchun Keygen Biological Products Co., Ltd. 497
Testing effectiveness (Phase 2)Study completedNCT03204227What this trial is testingSafety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of AgeWho this might be right forJapanese Encephalitis National Institute of Hygiene and Epidemiology, Vietnam 220